Our primary human endothelial cells have a distinguished resume of enabling research across a wide spectrum of applications. Just a few months ago, we highlighted the use of our human brain microvascular endothelial cells (HBMECs) (cat. HEC02) in an aging study that looked at cell senescence. However, if there is one area where our endothelial cells stand out, it's in diabetes research.
These cells have been utilized on several occasions to study and learn about how endothelial cells react to different glucose environments. Our endothelial cells were part of a study that proposed a drug to treat diabetic retinopathy. You can review all the ways our endothelial cells are being used here.
Image: Endothelial cells from different vascular beds display heterogeneous mitochondrial network morphology.
Then, just this past week, researchers at the University of Glasgow published a paper using our HBMECs to study diabetes.
The researchers compared the metabolic function of endothelial cells from different vascular beds throughout the body to various glucose conditions. They found that response varied greatly throughout the body. Their research has implications for therapeutics for diabetes, which is characterized by endothelial dysfunction. You can read the full study here.
Please check out all of our endothelial cells here. We have tons of readily available and research-proven options. Not needing endothelial cells? We offer several other human cell options—explore them all.